Navigation Links
Royalty Pharma Statement Regarding Elan Proposal

o in Royalty Pharma's Proposal;


Prothena Corporation plc;


Securities and Exchange Commission;

 "Specialty Pharma


Alkermes plc, Allergan, Inc., Cubist Pharmaceuticals, Inc., Endo Health Solutions 

Inc., Forest Laboratories, Inc., Jazz Pharmaceuticals plc, The Medicines Company,

Salix Pharmaceuticals, Ltd., Shire plc, Valeant Pharmaceuticals International, Inc. and Warner

Chilcott Plc;

 "Tysabri Conference Call"

the February 6, 2013 conference call following the announcement of the Tysabri Transaction;

 "Tysabri Consideration"

the consideration of US$3.249 billion payable by Biogen to Elan Group upon the completion of

the Tysabri Transaction;

 "Tysabri Royalty"

the royalty on Tysabri payable by Biogen to members of the Elan Group following the completion

of the Tysabri Transaction;

 "Tysabri Transaction"

the transaction between Elan and Biogen in relation to the restructuring of Elan's Tysabri collaboration with Biogen which was announced by Elan on February 6, 2013; and


Valeant Pharmaceuticals International, Inc. 

APPENDIX II: Chronology of EventsThe following chronology of recent events is provided as further background to the Proposal.

  • September 2011: Sale of Elan Drug Technologies (EDT) to Alkermes plc.
  • Summer 2012: Post-bapineuzumab clinical failure and announcement of spin-off of Prothena, Royalty Pharma developed an interest in Elan and Tysabri.
  • October to December 2012: Royalty Pharma had in-person meeting and several subsequent communications with Elan discussing ways in which Elan and Royalty Pharma might be able to work together, including Royalty Pharma's interest in potentially acquiring Elan.
  • 6 February 2013: Biogen and Elan announced Tysabri Transact

  • SOURCE RP Management, LLC
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

    Related biology technology :

    1. PDL BioPharma Provides Third Quarter 2012 Royalty Revenue Guidance of $85 Million
    2. Cowen Healthcare Royalty Partners Raises $1 Billion
    3. Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
    4. Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018: MarketResearchReports.Biz
    5. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
    6. AVANIR Pharmaceuticals To participate in two conferences in March
    7. Favorable Scenario for Japan Pharma Industry in Coming Years, New Report Says
    8. Hyperion Wins NDA Approval for UCD Drug Developed With Support from PharmaDirections
    9. Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies
    10. Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013
    11. Serialization in Pharmaceuticals, a Webinar Presented by Xtalks
    Post Your Comments:
    (Date:9/22/2014)... NEW YORK , Sept. 22, 2014 ... US demand for specialty biocides is forecast to ... 2018. In volume terms, demand is projected to increase ... the same period. A strong rebound in construction expenditures ... and paint and coatings markets, while growth in consumer ...
    (Date:9/22/2014)... DUBLIN , Sept. 22, 2014 ... the "Global and Chinese Microcrystalline Cellulose Industry Report ... The Global and Chinese Microcrystalline Cellulose Industry Report 2014 ... state of the global microcrystalline cellulose industry with a ... provides a basic overview of the industry including definitions, ...
    (Date:9/22/2014)... FierceBiotech today announced its annual “Fierce ... of 2014. FierceBiotech editors John Carroll and Damian ... winners. Those selected are identified as some of ... , "It's always a lot of fun ... companies," said Carroll. "This year in particular you'll find ...
    (Date:9/22/2014)... , Sept. 22, 2014 Synageva ... ), a biopharmaceutical company developing therapeutic products for ... Robert Bazemore as Chief Operating Officer.  Reporting ... and Chief Executive Officer, Robert will oversee the ... program, sebelipase alfa for LAL Deficiency, and will ...
    Breaking Biology Technology:US Biocides Market 2US Biocides Market 3Global and Chinese Microcrystalline Cellulose Industry Report 2014 2FierceBiotech Announces Annual “Fierce 15” Winners of 2014 2Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 2Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 3Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer 4
    ... Last night, as I watched my brothers set off marginally ... checked e-mail since Sunday morning, and my mobile phone was ... of July weekend, the mid-summer respite, and I felt anything ... hours even over a holiday weekend comes with ...
    ... as businesses seek to protect and enhance the value ... result of the business' products and services. Each year, ... many of them for federal trademark registration. Indeed, applications ... good leading indicator of economic conditions (a steep drop ...
    ... Madison, Wis. The National Institutes of ... a $4 million Fast-Track SBIR grant from the ... Diseases. , ,Under this grant, Stratatech will work ... substitute with enhanced antimicrobial and angiogenetic properties for ...
    Cached Biology Technology:Declaring independence from technology (sort of) 2Declaring independence from technology (sort of) 3Why file for trademark protection? 2Why file for trademark protection? 3Why file for trademark protection? 4
    (Date:9/22/2014)... in recent years has been identified as the plant,s ... aroma also summons beneficial insects to the rescue. , ... the environment via the emission of volatile organic compounds, ... wasps to come to the plant that is being ... Dr. Michael Kolomiets, Texas A&M AgriLife Research plant pathologist ...
    (Date:9/22/2014)... in a plant,s biological clock one that modulates ... , Transcription factors, or genetic switches, drive gene expression ... light, rain, soil quality, or even animals grazing on ... one, called FBH1, that reacts to temperature tweaking ... keeping it on a consistent track. , "Temperature helps ...
    (Date:9/22/2014)... CITY (September 22, 2014)The Brain & Behavior ... award of NARSAD Young Investigator Grants valued ... of the world,s most promising young scientists. ... groundbreaking neurobiological research will seek to identify ... for psychiatric disorders that affect one in ...
    Breaking Biology News(10 mins):Mown grass smell sends SOS for help in resisting insect attacks, researchers say 2Mown grass smell sends SOS for help in resisting insect attacks, researchers say 3Genetic switch regulates a plant's internal clock based on temperature 2Brain & Behavior Research Foundation awards 200 NARSAD Young Investigator grants 2
    ... for cystic fibrosis, HIV-fighting ,Trojan horses, new pharmaceuticals from ... to discover medications of the future. ,On 24 August, ... an international conference in Gothenburg, Sweden. In ... to investigate, and eventually control, the behavior of cells. ...
    ... researcher is challenging health standards that consider nitrates and ... research suggests that although there are negative health effects ... nitrates in groundwater, nitrates and nitrites -- as they ... Nitrate and nitrite are naturally occurring ions associated ...
    ... visceral fat, more commonly called belly fat, is known to ... causes visceral fat to accumulate? The culprit is likely ... hormone balance that occurs during the menopause transition, according to ... factors we analyzed that could possibly account for the increase ...
    Cached Biology News:10th Functional Genomics: Chemical Biology 2009 2Research supports calls to study health benefits of nitrate, nitrite 2Increase in visceral fat during menopause linked with testosterone 2
    ... of 3 siRNAs specifically targeted to your ... product. The siTrio reagent guarantees you get ... gene when used under standard conditions (100 ... optimal transfection with one of B-Bridges controls). ...
    ... a cocktail of 3 siRNAs specifically targeted ... most popular product. The siTrio reagent guarantees ... your target gene when used under standard ... confirmation of optimal transfection with one of ...
    ... has improved stability and convenience from the former ... has overcome this problem but also produced some ... the formulation of HRP conjugated antibody from lyophilized ... change, the stability of the conjugate has improved ...
    ... suitable for a wide range of molecular ... Pulsed Field Gel Electrophoresis (PFGE). Due to ... Multi ABgarose can effectively separate large DNA ... turn means reduced band diffusion, a problem ...
    Biology Products: